Latest News

Rapid-acting antidepressant for treatment-resistant depression: New insights

Researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression. The researchers found that by blocking NMDA receptors with the drug ketamine, they could elicit rapid antidepressant effects in patients with treatment-resistant depression. Ketamine was developed as an anesthetic, but is better known publicly for its abuse as the party drug Special K. Researchers are now seeking alternatives because ketamine can produce side effects that include hallucinations and the potential for abuse -- limiting its utility as an antidepressant.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • 'Exploding head syndrome' common in young people: Nearly one in five startled by loud, non-existent noises

  • Rats, reasoning, and rehabilitation: Neuroscientists are uncovering how we reason

  • Surprising source of serotonin could affect antidepressant activity

  • Adolescents' riskier online behavior suggests need for age-based warnings

  • Only one of 32 hockey helmets tested earn 3-star rating

  • Eating green leafy vegetables keeps mental abilities sharp

  • Alzheimer's: The killer protein, properly explained

  • New study of freelance workers examines link between their well-being and hours worked

  • Classroom behaviour and dyslexia research

  • Specific neurotransmitter receptor supports optimal information processing in the brain

  •